| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | AT 56 |
|---|
| Description | AT-56 is a selective, competitive, and highly bioavailable inhibitor of L-PGDS (lipocalin-type prostaglandin D synthase) (Ki = 75 μM). It inhibits the production of PGD2 by L-PGDS purified from human CSF and recombinant mouse cells with an IC50 value of 95 μM. At concentrations as high as 100 μM in vitro or 30 mg/kg in vivo, AT-56 does not affect the production of PGE2, PGF2α, or H-PGDS-catalyzed PGD2. MW: 397.52. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine |
|---|
| Gene, Accession, CAS # | CAS: 162640-98-4 |
|---|
| Catalog # | 2592-25 |
|---|
| Price | |
|---|
| Order / More Info | AT 56 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|